Skip to main content
SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)
Germany flag Germany · Delayed Price · Currency is EUR
27.90
-0.30 (-1.06%)
At close: Jun 3, 2025, 5:30 PM CET

ETR:1SXP Revenue

SCHOTT Pharma AG & Co. KGaA had revenue of 252.33M EUR in the quarter ending March 31, 2025, with 7.74% growth. This brings the company's revenue in the last twelve months to 972.81M, up 6.16% year-over-year. In the fiscal year ending September 30, 2024, SCHOTT Pharma AG & Co. KGaA had annual revenue of 957.09M with 6.51% growth.

Revenue (ttm)
972.81M
Revenue Growth
+6.16%
P/S Ratio
4.32
Revenue / Employee
203.09K
Employees
4,690
Market Cap
4.20B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Sep 30, 2024957.09M58.49M6.51%
Sep 30, 2023898.60M77.46M9.43%
Sep 30, 2022821.14M172.48M26.59%
Sep 30, 2021648.67M64.44M11.03%
Sep 30, 2020584.23M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Siemens Healthineers AG 23.14B
Merck KGaA 21.32B
Fresenius SE & Co. KGaA 22.13B
Bayer Aktiengesellschaft 46.58B
Fresenius Medical Care AG 19.49B
Sartorius Aktiengesellschaft 3.44B
Carl Zeiss Meditec AG 2.17B
Fielmann Group AG 2.33B
Revenue Rankings

SCHOTT Pharma AG & Co. KGaA News

More News